Understanding personal risk of oropharyngeal cancer: Risk-groups for oncogenic oral HPV infection and oropharyngeal cancer

Annals of Oncology

Volumn 28, Issue 12, 2017, Pages 3065-3069

  D'Souza, G ^a   McNeel, T S ^b   Fakhry, Carole ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Oral HPV; Oropharyngeal cancer; Risk groups; Risk triage; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH INFECTION; ORAL SEX; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SEX FACTOR; SEXUALITY; SMOKING; TOBACCO USE; VIRUS CARCINOGENESIS; CANCER REGISTRY; GENETICS; HEAD AND NECK TUMOR; ISOLATION AND PURIFICATION; MOUTH DISEASE; OROPHARYNX TUMOR; PATHOLOGY; RISK; SQUAMOUS CELL CARCINOMA; UNITED STATES; VIROLOGY; YOUNG ADULT;

VIRUS DNA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 85038855071     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdx535     Document Type: Article

References (16)

1. Saraiya M, Unger ER, Thompson TD et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 2015; 107(6): djv086
2. Jemal A, Simard EP, Dorell C et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013; 105(3): 175-201
3. Chaturvedi AK, Engels EA, Pfeiffer RM et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29(32): 4294-4301
4. D'Souza G, Cullen K, Bowie J et al. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One 2014; 9(1): e86023
5. D'Souza G, Zhang Y, Merritt S et al. Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer. Oral Oncol 2016; 60: 90-95
6. SEER Incidence and Incidence-Based Mortality Data, SEER 18 Regs (Excl Lousiana) 1973-2014; https://seer.cancer.gov/data/(8 May 2017, date last accessed)
7. Gillison ML, Broutian T, Pickard RKL et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307(7): 693-703
8. NHANES 2013-2014: Human Papillomavirus (HPV)-Oral Rinse Data Documentation, Codebook, and Frequencies; https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/ORHPV_H.htm (2 May 2017, date last accessed)
9. IARC. Human Papillmoaviruses; monographs.iarc.fr/ENG/Monographs/vol100B/mono100B-11.pdf (23 May 2017, date last accessed)
10. DevCan: Probability of Developing or Dying of Cancer-Surveillance Research Program; https://surveillance.cancer.gov/devcan/(8 May 2017, date last accessed)
11. D'Souza G, Wentz A, Kluz N et al. Sex differences in risk factors and natural history of oral human papillomavirus (HPV) infection. J Infect Dis 2016;213(12):1893-1896
12. Chaturvedi AK, Graubard BI, Broutian T et al. NHANES 2009-2012 findings: association of sexual behaviors with higher prevalence of oral oncogenic human papillomavirus infections in U.S. men. Cancer Res 2015; 75(12): 2468-2477
13. Beachler DC, Sugar EA, Margolick JB et al. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIVinfected and HIV-uninfected adults. Am J Epidemiol 2015; 181(1): 40-53
14. Pierce Campbell CM, Kreimer AR, Lin H-Y et al. Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study. Cancer Prev Res Phila Pa 2015; 8(3): 190-196
15. Holzinger D, Wichmann G, Baboci L et al. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma. Int J Cancer 2017; 140(12): 2748-2757
16. Beachler DC, Waterboer T, Pierce Campbell CM et al. HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection. Papillomavirus Res 2016; 2: 141-144